Stacey Tinianov: The reality of ‘manageable and tolerable’ side effects as well as risk reduction and management
Stacey Tinianov, Vice President of Patient Advocacy and Engagement at
“Trust me, we are all pretty excited about those survival curve improvements shared at SABCS23 ASH23, GI24, and the progress shared in the latest American Cancer Society report.
But we also need to talk about QUALITY of life.
Join us next week for a The Multinational Association of Supportive Care in Cancer (MASCC) webinar to chat about about the reality of ‘manageable and tolerable’ side effects as well as risk reduction and management.”
Quoting The Multinational Association of Supportive Care in Cancer’s post:
“Reminder! Join us on January 29 for a MASCC webinar:
GI Toxicities from Cancer Therapies – Prevention and Management
Speakers: Prof Maryam Lustberg, Stacey Tinianov, MPH, BCPA, Jill Feldman and Dr Ishwaria Subbiah, MD, MS.”
Learn more here.
Source: Stacey Tinianov/LinkedIn and The Multinational Association of Supportive Care in Cancer/LinkedIn